|
Antibodies |
||||
| Antibody |
Clone |
Dilution &condition |
Pretreatment |
Source |
|
|
||||
| Fas (C-20) |
1:200 RT1 h |
MWO-CB |
Santa Cruz Bio, Santa Cruz, CA, USA |
|
| FADD |
64A6 |
1:20 4°C overnight |
MWO-CB |
Novacastra, Newcastle upon Tyne, UK |
| Caspase 8 |
8CSP01 |
1:200 4°C overnight |
MWO-CB |
NeoMarkers, Fremont, CA, USA |
| CDC25B |
1:50 RT1 h |
MWO-CB |
Cell Signaling, Beverly, MA, USA |
|
| Fascin |
55K-2 |
1:50 RT1 h |
MWO-CB |
Dako Corp, Carpinteria, CA, USA |
| CK14 |
LL002 |
1:50 RT1 h |
MWO-CB |
NeoMarkers, Fremont, CA, USA |
| CK4 |
6B10 |
1:50 4°C overnight |
MWO-CB |
Novacastra, Newcastle upon Tyne, UK |
| Annexin 1 |
29 |
1:100 RT1 h |
MWO-CB |
BD Transduction Laboratories, Lexington, KY |
| Laminin-5γ2 |
D4B5 |
1:50 RT1 h |
Protease XXIV |
Chemicon, Temecula, CA, USA |
| SPARC |
15G12 |
1:50 RT1 h |
MWO-CB |
Novacastra, Newcastle upon Tyne, UK |
|
RT, room temperature MWO-CB, microwave oven heating in citrate buffer. | ||||
Xue et al. BMC Cancer 2006 6:296 doi:10.1186/1471-2407-6-296 |
||||